Biochem/physiol Actions

Reversible: no

Product does not compete with ATP.

Cell permeable: yes

Primary TargetA useful negative control for studies involving JNK Inhibitor I, (L)-Form, Cell-Permeable

General description

A highly cell-permeable carrier decapeptide derived from HIV-TAT_48-57 sequence that is modified with two proline residues. Serves as a useful negative control for studies involving JNK Inhibitor I, (L)-Form, Cell-permeable (Cat. No. 420116).

A highly cell-permeable 10-amino acid carrier peptide derived from HIV-TAT_48-57 sequence that is modified with two proline residues. Shown to accumulate into a variety of cells. Serves as a useful negative control for studies involving JNK Inhibitor I, (L)-Form, Cell-Permeable (Cat. No. 420116).

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Bonny, C., et al. 2001. Diabetes50, 77.Vocero-Akbani, A. M., et al 1999. Nat. Med.5, 29.Schwarze, S. R., et al. 1999. Science285, 1573.Nagahara, H., et al. 1998. Nat. Med.4, 1449.Vives, E., et al. 1997. J. Biol. Chem.272, 16010.

Packaging

1 mg in Plastic ampoule

Packaged under inert gas

Physical form

Supplied as a trifluoroacetate salt.

Reconstitution

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.

Sequence

H-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Pro-NH₂

Warning

Toxicity: Standard Handling (A)